跳至主要内容
临床试验/NCT01191827
NCT01191827已完成不适用

fMRI Cholinergic Mechanisms in Schizophrenia

US Department of Veterans Affairs1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Neuronal Response During Sensory Gating

研究概览

简要总结

This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.

详细描述

This study will use functional magnetic resonance imaging (fMRI) to study patients treated with risperidone, a commonly used neuroleptic that does not improves sensory gating, to those treated with clozapine to determine which brain areas are involved in clozapine's normalization of sensory gating in schizophrenia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of schizophrenia
  • age 18-60 yrs

排除标准

  • claustrophobia
  • weight > 250 lbs
  • metal in body other than dental fillings

结局指标

主要结局

Neuronal Response During Sensory Gating

时间窗: Immediate

Neuronal response (blood oxygenation level dependent functional magnetic resonance imaging signal, relative to the global mean) during sensory gating. Sensory gating is defined as the process of filtering out unnecessary environmental stimuli.

次要结局

未报告次要终点

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

fMRI Cholinergic Mechanisms in Schizophrenia | 临床试验